Lime Q2 2026 slides: growth accelerates, margins edge higher

Lime Technologies reported Q2 2026 net sales of SEK 205.3m (12% organic growth YoY) and 10% ARR growth, alongside adjusted EBITA of SEK 52.1m for a 25.4% margin. Management cited improving sequential momentum (ARR 9% in Q1 and 7% in Q4’25) and stronger traction in AI products plus deeper utility vertical penetration. Shares rose 9.38% to $227.5 pre-market as the company signaled progress toward long-term targets (18%+ ARR growth and 27%+ EBITA margin), while leverage remains low (net debt/EBITDA ~0.4x).

Analysis

The important signal is not the quarter’s absolute level, but that the business is re-accelerating while preserving margin discipline. For a subscale SaaS name, that combination usually matters more than headline growth because it lowers the probability of a value trap and increases the odds of self-funded expansion without dilution or balance-sheet stress. The market is likely underappreciating how much of the margin resilience comes from operating leverage in sales/support, which tends to compound once net retention stabilizes.

Over the next 1-3 months, the key question is whether the traction in Germany and utility verticals is repeatable or just a good pipeline quarter. If repeatable, LIME becomes a cleaner beneficiary of European data-sovereignty and vertical-software demand, and that creates second-order pressure on generic CRM platforms whose differentiation is mostly workflow breadth rather than local domain depth. The spillover matters most for mid-market incumbents with weaker implementation moats; they may have to trade more price or services to defend renewals.

The contrarian view is that the market may be extrapolating AI optionality too quickly: beta products do not equal monetization, and the current growth rate is still not close to the company’s own long-term hurdle. The thesis breaks if ARR growth slips back toward high-single digits or if the next update shows that AI adoption is additive only at the sales-demo level. On a 6-18 month horizon, M&A is the real catalyst to watch, but it is also the main risk if management uses the strong balance sheet to buy growth at the wrong price rather than letting core execution compound.

Key Decisions for Investors

• Tactically go long LIME on post-earnings weakness only after the gap holds for 2-3 sessions; use a tight stop on a gap fill because the immediate move is likely momentum-driven, not yet fundamental re-rating.
• If you want relative-value exposure, pair long LIME vs short HUBS or CRM over 3-6 months: the long leg is the European vertical-software monetization story; the short leg is a generic horizontal CRM basket more exposed to feature commoditization.
• Do not use options unless liquidity is clearly sufficient; stock is the cleaner vehicle here because the main risk is an earnings-gap fade, not a binary event.
• Set an alert for the next ARR print: add to longs only if growth inflects into the 12-13% area; reduce/exit if it slips below 9%, which would suggest the current enthusiasm is premature.
• Treat any announced acquisition as a sell-the-news event unless the target is immediately accretive and preserves the 25%+ margin profile; otherwise the multiple is likely to compress.